756 related articles for article (PubMed ID: 23416106)
1. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
2. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Poortman J; Prenen JA; Schwarz F; Thijssen JH
J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
[TBL] [Abstract][Full Text] [Related]
3. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta.
Norata GD; Cattaneo P; Poletti A; Catapano AL
Atherosclerosis; 2010 Sep; 212(1):100-6. PubMed ID: 20557886
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells.
Hackenberg R; Turgetto I; Filmer A; Schulz KD
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):597-603. PubMed ID: 8240982
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
6. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
7. Assessment of steroidogenesis and steroidogenic enzyme functions.
Luu-The V
J Steroid Biochem Mol Biol; 2013 Sep; 137():176-82. PubMed ID: 23770321
[TBL] [Abstract][Full Text] [Related]
8. CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling.
Pettersson H; Holmberg L; Axelson M; Norlin M
FEBS J; 2008 Apr; 275(8):1778-89. PubMed ID: 18331353
[TBL] [Abstract][Full Text] [Related]
9. Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
Hanamura T; Niwa T; Gohno T; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2014 Jan; 143(1):69-80. PubMed ID: 24292869
[TBL] [Abstract][Full Text] [Related]
10. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
[TBL] [Abstract][Full Text] [Related]
11. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
[TBL] [Abstract][Full Text] [Related]
12. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
13. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.
Miyamoto H; Yeh S; Lardy H; Messing E; Chang C
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11083-8. PubMed ID: 9736693
[TBL] [Abstract][Full Text] [Related]
14. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol.
Honma N; Saji S; Hirose M; Horiguchi S; Kuroi K; Hayashi S; Utsumi T; Harada N
Cancer Sci; 2011 Oct; 102(10):1848-54. PubMed ID: 21707867
[TBL] [Abstract][Full Text] [Related]
16. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
[TBL] [Abstract][Full Text] [Related]
17. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of 18 steroids in human and mouse serum by liquid chromatography-mass spectrometry without derivatization to profile the classical and alternate pathways of androgen synthesis and metabolism.
Desai R; Harwood DT; Handelsman DJ
Clin Mass Spectrom; 2019 Jan; 11():42-51. PubMed ID: 34841072
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells.
Chang HC; Miyamoto H; Marwah P; Lardy H; Yeh S; Huang KE; Chang C
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11173-7. PubMed ID: 10500149
[TBL] [Abstract][Full Text] [Related]
20. C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists.
Marwah P; Marwah A; Lardy HA; Miyamoto H; Chang C
Bioorg Med Chem; 2006 Sep; 14(17):5933-47. PubMed ID: 16759873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
